[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Biopharma_Watch BiopharmaWatch BiopharmaWatch posts on X about $iobt, $apm, $sttk, $lyra the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1734221906151165952/interactions)  - X Week XXXXX +11% - X Month XXXXXX -XX% - X Months XXXXXXX +49% - X Year XXXXXXX +288% ### Mentions: XX [#](/creator/twitter::1734221906151165952/posts_active)  - X Week XX +29% - X Month XXX -XX% - X Months XXX +774% - X Year XXXXX +1,716% ### Followers: XXXXX [#](/creator/twitter::1734221906151165952/followers)  - X Week XXXXX +1.90% - X Month XXXXX +4.70% - X Months XXXXX +73% - X Year XXXXX +63% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1734221906151165952/influencer_rank)  ### Social Influence [#](/creator/twitter::1734221906151165952/influence) --- **Social category influence** [finance](/list/finance) XXX% [cryptocurrencies](/list/cryptocurrencies) XXX% [stocks](/list/stocks) XXX% **Social topic influence** [$iobt](/topic/$iobt) #22, [$apm](/topic/$apm) 1.4%, [$sttk](/topic/$sttk) 1.4%, [$lyra](/topic/$lyra) 1.4%, [chronic](/topic/chronic) 1.4%, [$artv](/topic/$artv) 1.4%, [$xrtx](/topic/$xrtx) #23, [$rani](/topic/$rani) #184, [apm](/topic/apm) 0.7%, [$iron](/topic/$iron) XXX% **Top assets mentioned** [apM Coin (APM)](/topic/$apm) [LYRA (LYRA)](/topic/$lyra) [Disc Medicine, Inc. Common Stock (IRON)](/topic/$iron) [Bruker, Corp. (BRKR)](/topic/$brkr) [Pfizer, Inc. (PFE)](/topic/$pfe) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Glaukos Corporation (GKOS)](/topic/$gkos) [Avantor, Inc. (AVTR)](/topic/$avtr) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) ### Top Social Posts [#](/creator/twitter::1734221906151165952/posts) --- Top posts by engagements in the last XX hours "Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives" [X Link](https://x.com/Biopharma_Watch/status/1976675349451903424) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-10T15:45Z 1136 followers, XXX engagements "$IRON 89.61$ XXXXX% October XX 2025 Disc Medicine Announces Receipt of FDA Commissioners National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)" [X Link](https://x.com/Biopharma_Watch/status/1979212079086342462) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XX engagements "Top Market Movers: Negative News Full Access: $BRKR 29.35$ -XXXXX% September X 2025 Bruker Announces Pricing of Public Offering of $XXX Million of XXXXX% Mandatory Convertible Preferred Stock" [X Link](https://x.com/Biopharma_Watch/status/1963597430433120468) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-04T13:38Z 1135 followers, XXX engagements "Top Market Movers: Negative News Full Access: $ACTU 6.97$ -XXXXX% September XX 2025 Actuate Therapeutics Announces Proposed Public Offering of Common Stock" [X Link](https://x.com/Biopharma_Watch/status/1965803717229502904) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-10T15:45Z 1135 followers, XXX engagements "Latest catalysts: $RNXT Catalyst Date - 2025-09-16 Drug - RenovoCath (intra-arterial gemcitabine delivered via RenovoCath known as IAG) Treatment - locally advanced pancreatic cancer (LAPC)" [X Link](https://x.com/Biopharma_Watch/status/1967978045727514710) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-16T15:45Z 1135 followers, XXX engagements "Top Market Movers: Positive News Full Access: $ADXN 10.17$ XXXXX% September XX 2025 Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update" [X Link](https://x.com/Biopharma_Watch/status/1973051471601205324) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-30T15:45Z 1135 followers, XXX engagements "Top Market Movers: Negative News Full Access: $ARTL 4.75$ -XXXXX% September XX 2025 Artelo Biosciences Announces Presentation of Positive Interim Phase X CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference" [X Link](https://x.com/Biopharma_Watch/status/1973051475686494652) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-30T15:45Z 1133 followers, XXX engagements "$PFE 26.98$ XXXX% October XX 2025 Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025" [X Link](https://x.com/Biopharma_Watch/status/1973413886855618891) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-01T15:45Z 1135 followers, XX engagements "Latest catalysts: $STTK Catalyst Date - 2025-10-08 Drug - SL-325 (Death Receptor X blocking antibody) Treatment - Inflammatory bowel disease (IBD) inflammatory and immune-related diseases" [X Link](https://x.com/Biopharma_Watch/status/1975588187369255290) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-07T15:45Z 1135 followers, XXX engagements "Latest catalysts: $STTK Catalyst Date - 2025-10-08 Drug - SL-325 (Death Receptor X blocking antibody) Treatment - Inflammatory bowel disease (IBD) inflammatory and immune-related diseases" [X Link](https://x.com/Biopharma_Watch/status/1975950576883286148) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-08T15:45Z 1135 followers, XXX engagements "$DYN Catalyst Date - 2025-10-08 Drug - zeleciment basivarsen (z-basivarsen formerly known as DYNE-101) Treatment - myotonic dystrophy type X (DM1)" [X Link](https://x.com/Biopharma_Watch/status/1975950589998907721) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-08T15:45Z 1135 followers, XX engagements "Top Market Movers: Negative News Full Access: $GTBP 0.74$ -XXXXX% October X 2025 GT Biopharma Provides Enrollment Update on GTB-3650 Phase X Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Ma" [X Link](https://x.com/Biopharma_Watch/status/1976312963482153034) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-09T15:45Z 1133 followers, XXX engagements "Latest catalysts: $SGMT Catalyst Date - 2025-10-09 Drug - denifanstat (selective FASN inhibitor) Treatment - metabolic dysfunction associated steatohepatitis (MASH)" [X Link](https://x.com/Biopharma_Watch/status/1976312964266459389) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-09T15:45Z 1135 followers, XXX engagements "$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)" [X Link](https://x.com/Biopharma_Watch/status/1976312990740918518) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-09T15:45Z 1135 followers, XX engagements "Latest catalysts: $RVPH Catalyst Date - 2025-10-10 Drug - brilaroxazine (RP5063) Treatment - schizophrenia" [X Link](https://x.com/Biopharma_Watch/status/1976675350945104223) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-10T15:45Z 1135 followers, XXX engagements "$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)" [X Link](https://x.com/Biopharma_Watch/status/1976675364224311702) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-10T15:45Z 1135 followers, XXX engagements "$APM 1.45$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives" [X Link](https://x.com/Biopharma_Watch/status/1977762531327496532) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-13T15:45Z 1135 followers, XX engagements "$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors" [X Link](https://x.com/Biopharma_Watch/status/1978487338495001020) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-15T15:45Z 1135 followers, XXX engagements "$GKOS 83.69$ -XXXX% October XX 2025 Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting" [X Link](https://x.com/Biopharma_Watch/status/1978487338813808952) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-15T15:45Z 1135 followers, XXX engagements "Top Market Movers: Positive News Full Access: $ANVS 2.16$ XXXXX% October XX 2025 Annovis Announces Closing of $X Million Registered Direct Offering of Common Stock" [X Link](https://x.com/Biopharma_Watch/status/1978849678491025832) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1135 followers, XXX engagements "$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors" [X Link](https://x.com/Biopharma_Watch/status/1978849701761065232) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1135 followers, XXX engagements "$SYRE 23.30$ XXXX% October XX 2025 Spyre Therapeutics Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $XXXXX Million" [X Link](https://x.com/Biopharma_Watch/status/1978849708924932243) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1135 followers, XX engagements "$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - Squamous cell carcinoma of head and neck (SCCHN)" [X Link](https://x.com/Biopharma_Watch/status/1978849716428587171) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1135 followers, XXX engagements "$AVTR 14.48$ XXXX% October XX 2025 Avantor and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology" [X Link](https://x.com/Biopharma_Watch/status/1978849726092177864) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1135 followers, XXX engagements "Top Market Movers: Positive News Full Access: $ARTV 5.46$ XXXXX% October XX 2025 Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication Upcoming Data Releases and Corporate Update" [X Link](https://x.com/Biopharma_Watch/status/1979212068462235696) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements "Top Market Movers: Negative News Full Access: $RCEL 3.95$ -XXXXX% October XX 2025 AVITA Medical Announces CEO Transition" [X Link](https://x.com/Biopharma_Watch/status/1979212071897292925) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements "Latest catalysts: $IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors" [X Link](https://x.com/Biopharma_Watch/status/1979212072673251532) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements "Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $XRTX - 2.7M - 78.9M - XXXXX $RANI - 8.0M - 230.1M - XXXXX $ARTV - 2.7M - 55.5M - 20.78" [X Link](https://x.com/Biopharma_Watch/status/1979212073365311895) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements "$PRAX 183.28$ XXXXX% October XX 2025 Praxis Precision Medicines Inc. Announces Pricing of $XXX Million Public Offering" [X Link](https://x.com/Biopharma_Watch/status/1979212092625568164) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XX engagements "$AGIO 42.50$ XXXX% October XX 2025 Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October XX at 8:00 a.m. ET" [X Link](https://x.com/Biopharma_Watch/status/1979212105065886094) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements "$TSHA 4.50$ -XXXXX% October XX 2025 Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome" [X Link](https://x.com/Biopharma_Watch/status/1979212118504411224) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements "Top Market Movers: Positive News Full Access: $RANI 2.15$ XXXXX% October XX 2025 Rani Therapeutics Announces up to $XXXXX Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including R" [X Link](https://x.com/Biopharma_Watch/status/1980299231576666219) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-20T15:45Z 1135 followers, XXX engagements "Top Market Movers: Negative News Full Access: $XRTX 0.80$ -XXXXX% October XX 2025 XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems" [X Link](https://x.com/Biopharma_Watch/status/1980299235703820620) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-20T15:45Z 1135 followers, XXX engagements "Latest catalysts: $BCTX Catalyst Date - 2025-10-20 Drug - Bria-IMT Treatment - Advanced Metastatic Breast Cancer" [X Link](https://x.com/Biopharma_Watch/status/1980299237217988612) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-20T15:45Z 1135 followers, XXX engagements "$GMAB 31.11$ -XXXX% October XX 2025 Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer" [X Link](https://x.com/Biopharma_Watch/status/1980299265089163284) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-20T15:45Z 1135 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Biopharma_Watch BiopharmaWatch
BiopharmaWatch posts on X about $iobt, $apm, $sttk, $lyra the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +11%
- X Month XXXXXX -XX%
- X Months XXXXXXX +49%
- X Year XXXXXXX +288%
Mentions: XX #
- X Week XX +29%
- X Month XXX -XX%
- X Months XXX +774%
- X Year XXXXX +1,716%
Followers: XXXXX #
- X Week XXXXX +1.90%
- X Month XXXXX +4.70%
- X Months XXXXX +73%
- X Year XXXXX +63%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance XXX% cryptocurrencies XXX% stocks XXX%
Social topic influence $iobt #22, $apm 1.4%, $sttk 1.4%, $lyra 1.4%, chronic 1.4%, $artv 1.4%, $xrtx #23, $rani #184, apm 0.7%, $iron XXX%
Top assets mentioned apM Coin (APM) LYRA (LYRA) Disc Medicine, Inc. Common Stock (IRON) Bruker, Corp. (BRKR) Pfizer, Inc. (PFE) Dyne Therapeutics, Inc. Common Stock (DYN) Glaukos Corporation (GKOS) Avantor, Inc. (AVTR) Praxis Precision Medicines, Inc. Common Stock (PRAX) Agios Pharmaceuticals, Inc. (AGIO)
Top Social Posts #
Top posts by engagements in the last XX hours
"Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1136 followers, XXX engagements
"$IRON 89.61$ XXXXX% October XX 2025 Disc Medicine Announces Receipt of FDA Commissioners National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)"
X Link @Biopharma_Watch 2025-10-17T15:45Z 1135 followers, XX engagements
"Top Market Movers: Negative News Full Access: $BRKR 29.35$ -XXXXX% September X 2025 Bruker Announces Pricing of Public Offering of $XXX Million of XXXXX% Mandatory Convertible Preferred Stock"
X Link @Biopharma_Watch 2025-09-04T13:38Z 1135 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $ACTU 6.97$ -XXXXX% September XX 2025 Actuate Therapeutics Announces Proposed Public Offering of Common Stock"
X Link @Biopharma_Watch 2025-09-10T15:45Z 1135 followers, XXX engagements
"Latest catalysts: $RNXT Catalyst Date - 2025-09-16 Drug - RenovoCath (intra-arterial gemcitabine delivered via RenovoCath known as IAG) Treatment - locally advanced pancreatic cancer (LAPC)"
X Link @Biopharma_Watch 2025-09-16T15:45Z 1135 followers, XXX engagements
"Top Market Movers: Positive News Full Access: $ADXN 10.17$ XXXXX% September XX 2025 Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update"
X Link @Biopharma_Watch 2025-09-30T15:45Z 1135 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $ARTL 4.75$ -XXXXX% September XX 2025 Artelo Biosciences Announces Presentation of Positive Interim Phase X CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference"
X Link @Biopharma_Watch 2025-09-30T15:45Z 1133 followers, XXX engagements
"$PFE 26.98$ XXXX% October XX 2025 Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025"
X Link @Biopharma_Watch 2025-10-01T15:45Z 1135 followers, XX engagements
"Latest catalysts: $STTK Catalyst Date - 2025-10-08 Drug - SL-325 (Death Receptor X blocking antibody) Treatment - Inflammatory bowel disease (IBD) inflammatory and immune-related diseases"
X Link @Biopharma_Watch 2025-10-07T15:45Z 1135 followers, XXX engagements
"Latest catalysts: $STTK Catalyst Date - 2025-10-08 Drug - SL-325 (Death Receptor X blocking antibody) Treatment - Inflammatory bowel disease (IBD) inflammatory and immune-related diseases"
X Link @Biopharma_Watch 2025-10-08T15:45Z 1135 followers, XXX engagements
"$DYN Catalyst Date - 2025-10-08 Drug - zeleciment basivarsen (z-basivarsen formerly known as DYNE-101) Treatment - myotonic dystrophy type X (DM1)"
X Link @Biopharma_Watch 2025-10-08T15:45Z 1135 followers, XX engagements
"Top Market Movers: Negative News Full Access: $GTBP 0.74$ -XXXXX% October X 2025 GT Biopharma Provides Enrollment Update on GTB-3650 Phase X Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Ma"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1133 followers, XXX engagements
"Latest catalysts: $SGMT Catalyst Date - 2025-10-09 Drug - denifanstat (selective FASN inhibitor) Treatment - metabolic dysfunction associated steatohepatitis (MASH)"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1135 followers, XXX engagements
"$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)"
X Link @Biopharma_Watch 2025-10-09T15:45Z 1135 followers, XX engagements
"Latest catalysts: $RVPH Catalyst Date - 2025-10-10 Drug - brilaroxazine (RP5063) Treatment - schizophrenia"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1135 followers, XXX engagements
"$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)"
X Link @Biopharma_Watch 2025-10-10T15:45Z 1135 followers, XXX engagements
"$APM 1.45$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link @Biopharma_Watch 2025-10-13T15:45Z 1135 followers, XX engagements
"$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1135 followers, XXX engagements
"$GKOS 83.69$ -XXXX% October XX 2025 Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting"
X Link @Biopharma_Watch 2025-10-15T15:45Z 1135 followers, XXX engagements
"Top Market Movers: Positive News Full Access: $ANVS 2.16$ XXXXX% October XX 2025 Annovis Announces Closing of $X Million Registered Direct Offering of Common Stock"
X Link @Biopharma_Watch 2025-10-16T15:45Z 1135 followers, XXX engagements
"$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors"
X Link @Biopharma_Watch 2025-10-16T15:45Z 1135 followers, XXX engagements
"$SYRE 23.30$ XXXX% October XX 2025 Spyre Therapeutics Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $XXXXX Million"
X Link @Biopharma_Watch 2025-10-16T15:45Z 1135 followers, XX engagements
"$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - Squamous cell carcinoma of head and neck (SCCHN)"
X Link @Biopharma_Watch 2025-10-16T15:45Z 1135 followers, XXX engagements
"$AVTR 14.48$ XXXX% October XX 2025 Avantor and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology"
X Link @Biopharma_Watch 2025-10-16T15:45Z 1135 followers, XXX engagements
"Top Market Movers: Positive News Full Access: $ARTV 5.46$ XXXXX% October XX 2025 Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication Upcoming Data Releases and Corporate Update"
X Link @Biopharma_Watch 2025-10-17T15:45Z 1135 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $RCEL 3.95$ -XXXXX% October XX 2025 AVITA Medical Announces CEO Transition"
X Link @Biopharma_Watch 2025-10-17T15:45Z 1135 followers, XXX engagements
"Latest catalysts: $IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors"
X Link @Biopharma_Watch 2025-10-17T15:45Z 1135 followers, XXX engagements
"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $XRTX - 2.7M - 78.9M - XXXXX $RANI - 8.0M - 230.1M - XXXXX $ARTV - 2.7M - 55.5M - 20.78"
X Link @Biopharma_Watch 2025-10-17T15:45Z 1135 followers, XXX engagements
"$PRAX 183.28$ XXXXX% October XX 2025 Praxis Precision Medicines Inc. Announces Pricing of $XXX Million Public Offering"
X Link @Biopharma_Watch 2025-10-17T15:45Z 1135 followers, XX engagements
"$AGIO 42.50$ XXXX% October XX 2025 Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October XX at 8:00 a.m. ET"
X Link @Biopharma_Watch 2025-10-17T15:45Z 1135 followers, XXX engagements
"$TSHA 4.50$ -XXXXX% October XX 2025 Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome"
X Link @Biopharma_Watch 2025-10-17T15:45Z 1135 followers, XXX engagements
"Top Market Movers: Positive News Full Access: $RANI 2.15$ XXXXX% October XX 2025 Rani Therapeutics Announces up to $XXXXX Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including R"
X Link @Biopharma_Watch 2025-10-20T15:45Z 1135 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $XRTX 0.80$ -XXXXX% October XX 2025 XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems"
X Link @Biopharma_Watch 2025-10-20T15:45Z 1135 followers, XXX engagements
"Latest catalysts: $BCTX Catalyst Date - 2025-10-20 Drug - Bria-IMT Treatment - Advanced Metastatic Breast Cancer"
X Link @Biopharma_Watch 2025-10-20T15:45Z 1135 followers, XXX engagements
"$GMAB 31.11$ -XXXX% October XX 2025 Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer"
X Link @Biopharma_Watch 2025-10-20T15:45Z 1135 followers, XXX engagements